Eris has formed a JV with MJ Biopharm for this purpose.
Key points to note –
- Eris will hold 70% of the JV and MJ 30%.
- MJ is also getting Rs 15 crore as one time lump sum licence fee.
- MJ will be responsible for development of products and Eris marketing of those.
JV seems to be a step in the right direction.